Depuis 1984, ATC a développé au sein de son unité de pharmacologie clinique une grande expertise dans les essais de phases 0, I et II. Celle-ci lui permet d’offrir à ses clients un soutien professionnel et scientifique aux essais cliniques mais aussi aux processus de décisions lors des phases initiales du développement de leurs nouvelles molécules. Tout en respectant des standards de qualité visant à garantir la sécurité des sujets ainsi que la fiabilité des données collectées, ATC a ainsi pu accroitre son expertise médicale dans de multiples domaines tels que le diabète, la dépression, la douleur, l’hypertension, l’hépatite, les troubles endocriniens, l’arthrose, la neurologie, la pneumologie, etc. Chez ATC, vous aurez l’opportunité d’intégrer une équipe motivée et compétente, active au sein d’une entreprise à taille humaine, et aurez pour mission d’apporter à vos clients un service de qualité, adapté à leurs besoins. Vous aurez notamment accès à une base de données de plus de 2000 volontaires sains ainsi qu’aux patients du C.H.U. de Liège et aux expertises scientifiques et techniques de l’hôpital académique ! (http://www.atc-pharma.be/fr)

lire plus


Located in Laguna Hills, California, USA, and Mont St-Guibert, Belgium, Metronom Health—which is a portfolio company of Fjord Ventures LLC, a life science technology accelerator—is a thriving, fast-paced development company with an entrepreneurial environment. Leveraging its accelerator operating model, Fjord Ventures creates capital-efficient companies. These efficiencies are achieved through the broad experience of management, shared infrastructure and a dedicated source of funding that allows Fjord’s portfolio companies to focus on product innovation and disruptive technologies. This culture incentivizes progress and nurtures highly motivated, idea-driven spaces, where groundbreaking technology like Metronom Health Continuous Glucose Monitoring can take hold. Metronom Health is prepared to revolutionize the management of diabetes. We envision a world where the effort of diabetes management does not consume the lives of people living with diabetes, as well as those who care for them: Less thinking. Less worrying. More doing. This principle is at the core of the development of their Mobile App based solution. That is their daily, unwavering focus at Metronom Health. Leveraging its innovative and unique technology, Metronom is committed to developing and commercializing a revolutionary Continuous Glucose Monitoring solution, which will be deeply rooted in users’ individual needs, and shaped by the overall healthcare system, aiming to define a new standard of care in the management of diabetes. To reinforce their team, we are currently looking for a talented experienced Mobile App Test Engineer

lire plus


Founded in 1962, Hospithera is a Belgian company which distributes medical devices designed by reliable and internationally well-known suppliers. Over the years, Hospithera has become the preferred partner of hospitals and health professionals in providing bespoke solutions through its committed sales force. The company is active in 5 main fields of activities: • Critical Care: focuses on the needs of the operating room • Sterilization & Hygiene: the best solution for everything related to medical hygiene • Sterilization Equipment: supply you with solution and service for your central sterilization department • Interventional Care: further subdivided into the Interventional Specialties, Wound care, Vital Care, Daycare and Daycare NL departments • Surgery: further subdivided into Cardio-vascular and Spine departments Each Division offers a complete package of disposables, capital equipment and services to meet its customers' changing needs. In 2017 Hospithera distributes 150 reliable brands of medical devices, on the Benelux market and offers integrated solutions for different groups of customers groups in Belgium and Luxemburg. The turnover of Hospithera grew for the tenth consecutive year. To reinforce their team, they are currently looking for a talented and motivated QA/RA Officer with a QP certification.

lire plus


Context and Company The International Diabetes Federation estimates at 415 million the number of people living with Diabetes - one in eleven! - and predicts that this number will grow and reach 642 million in 2040. Glycemic control is an essential part of diabetes management, aiming to avoid short and long-term complications associated with the condition. Glycemic control must therefore be measured in a rigorous and reliable way on a daily basis, in order to support the multiple decision-making specific to the management of the condition, and maintain blood sugar levels in the desired levels. With the availability of continuous glucose monitoring systems, aiming to provide users continuous visibility on their blood sugar level to optimize their treatment and improve their quality of life, diabetes management is entering a new era. And despite recent advancements, current available products still have some important shortfalls in helping people living their life with diabetes, not the other way around. And this is at the core of Metronom Health’s mission and vision, consisting of developing and designing a new continuous glucose monitoring system, aiming at making diabetes a smaller part of life. Their disruptive technology aims at providing people living with diabetes and those caring for them with an accurate, reliable, user friendly and affordable continuous glucose monitoring system. Their CGM (Continuous Glucose Monitoring) system aims at significantly reduce both the short and long term health complications associated with uncontrolled or poorly managed blood glucose levels, whilst improving the day to day quality of life of people living with diabetes. A first in Human proof on concept study has been completed successfully, and they are now fully engaged in the development of the commercial product, targeting a market release in Europe by 2019. To reinforce their team, we are currently looking for a talented experienced Lead iOS App Developer

lire plus


Context and Company The International Diabetes Federation estimates at 415 million the number of people living with Diabetes - one in eleven! - and predicts that this number will grow and reach 642 million in 2040. Glycemic control is an essential part of diabetes management, aiming to avoid short and long-term complications associated with the condition. Glycemic control must therefore be measured in a rigorous and reliable way on a daily basis, in order to support the multiple decision-making specific to the management of the condition, and maintain blood sugar levels in the desired levels. With the availability of continuous glucose monitoring systems, aiming to provide users continuous visibility on their blood sugar level to optimize their treatment and improve their quality of life, diabetes management is entering a new era. And despite recent advancements, current available products still have some important shortfalls in helping people living their life with diabetes, not the other way around. And this is at the core of Metronom Health’s mission and vision, consisting of developing and designing a new continuous glucose monitoring system, aiming at making diabetes a smaller part of life. Our disruptive technology aims at providing people living with diabetes and those caring for them with an accurate, reliable, user friendly and affordable continuous glucose monitoring system. Our CGM (Continuous Glucose Monitoring) system aims at significantly reduce both the short and long term health complications associated with uncontrolled or poorly managed blood glucose levels, whilst improving the day to day quality of life of people living with diabetes. A first in Human proof on concept study has been completed successfully, and we are now fully engaged in the development of the commercial product, targeting a market release in Europe by 2019. It's time to reinforce our team. We are currently looking for a talented Mobile App Test Engineer

lire plus


Context and Company: The International Diabetes Federation estimates at 415 million the number of people living with Diabetes - one in eleven! - and predicts that this number will grow and reach 642 million in 2040. Glycemic control is an essential part of diabetes management, aiming to avoid short and long-term complications associated with the condition. Glycemic control must therefore be measured in a rigorous and reliable way on a daily basis, in order to support the multiple decision-making specific to the management of the condition, and maintain blood sugar levels in the desired levels. With the availability of continuous glucose monitoring systems, aiming to provide users continuous visibility on their blood sugar level to optimize their treatment and improve their quality of life, diabetes management is entering a new era. And despite recent advancements, current available products still have some important shortfalls in helping people living their life with diabetes, not the other way around. And this is at the core of Metronom Health’s mission and vision, consisting of developing and designing a new continuous glucose monitoring system, aiming at making diabetes a smaller part of life. The Metronom’s disruptive technology aims at providing people living with diabetes and those caring for them with an accurate, reliable, user friendly and affordable continuous glucose monitoring system. Their CGM (Continuous Glucose Monitoring) system aims at significantly reduce both the short and long term health complications associated with uncontrolled or poorly managed blood glucose levels, whilst improving the day to day quality of life of people living with diabetes. A first in Human proof on concept study has been completed successfully, and they are now fully engaged in the development of the commercial product, targeting a market release in Europe by 2019. It's time to reinforce their team. We are currently looking for a talented Embedded system Test engineer (1 year contract).

lire plus


Context and Company: The International Diabetes Federation estimates at 415 million the number of people living with Diabetes - one in eleven! - and predicts that this number will grow and reach 642 million in 2040. Glycemic control is an essential part of diabetes management, aiming to avoid short and long-term complications associated with the condition. Glycemic control must therefore be measured in a rigorous and reliable way on a daily basis, in order to support the multiple decision-making specific to the management of the condition, and maintain blood sugar levels in the desired levels. With the availability of continuous glucose monitoring systems, aiming to provide users continuous visibility on their blood sugar level to optimize their treatment and improve their quality of life, diabetes management is entering a new era. And despite recent advancements, current available products still have some important shortfalls in helping people living their life with diabetes, not the other way around. And this is at the core of Metronom Health’s mission and vision, consisting of developing and designing a new continuous glucose monitoring system, aiming at making diabetes a smaller part of life. Their disruptive technology aims at providing people living with diabetes and those caring for them with an accurate, reliable, user friendly and affordable continuous glucose monitoring system. Our CGM (Continuous Glucose Monitoring) system aims at significantly reduce both the short and long term health complications associated with uncontrolled or poorly managed blood glucose levels, whilst improving the day to day quality of life of people living with diabetes. A first in Human proof on concept study has been completed successfully, and we are now fully engaged in the development of the commercial product, targeting a market release in Europe by 2019. It's time to reinforce our team. For our client Metronom Health, we are urgently looking for a talented BLE Firmware Engineer (6 months contract, extension likely)

lire plus


Auxin Surgery develops and sells medical surgical devices. Several ground-breaking products will be submitted for CE marking in May 2017, and will be put on sale by the end of the year. These products are designed to make complex medical procedures more straightforward and to reduce serious harmful side effects. These have been shown to do so in clinical studies involving over 800 patients. Auxin Surgery is planning to launch this product range in Europe initially, after obtaining CE marking, but before seeking FDA approval.

lire plus


Cenexi LT is a young high-tech CDMO (Contract Development & Manufacturing Organisation) with a high growth potential and specialised in injectable pharmaceutical products for treating cancer. Cenexi LT is part of the French Cenexi group, one of the leading CMOs on the European market with more than 900 employees. Our main asset is the presence and integration at a single site in Braine L'Alleud, Belgium, of a manufacturing entity as well as a Research and Development unit. Our organisation also stands out by bringing together operational skills and technical and scientific competencies in a stimulating and developing environment. In addition, we also have the opportunity to work on a broad variety of products that focus on the real needs of the market. Our clients include a wide range of top 10 companies, from big pharmas, start-ups, and young innovative biotech firms. We employ more than 200 employees and are currently seeking for our teams new talent who have an entrepreneurial spirit, the desire to contribute to a team project, as well as the ability to inspire and energise their environment, combined with technical and/or scientific expertise. We are seeking candidates who are attracted by a human-sized working environment and a company where decisions directly influence the results of the organisation and where anticipation and actions are major assets.

lire plus


Digital Orthopaedics is a digital Health company providing worldwide access to a comprehensive Clinical Decision Support System (CDSS) for musculoskeletal pathologies. Our ambition is to improve patient treatment by providing caregivers, surgeons patients and medical devices companies with a state of the art CDSS. Our mission is to identify the optimum treatment and surgical therapeutic plan for each patient and assist medical devices companies to conduct virtual clinical studies for the testing of implants and prosthetic ankles. If you are sharing our vision of developing life-improving services and if you are looking for digital health development challenges amongst a dynamic and innovative team, consider collaboration with our fast-growing company. (http://www.digital-orthopaedics.com/)

lire plus


CluePoints is a fast-growing company and the premier provider of Risk-Based Monitoring and Data Quality Oversight Software to Bio-Pharmaceutical and Medical Device organizations. Our software utilizes advanced statistical algorithms to determine the quality of clinical trial data. The value of CluePoints lies in its powerful and timely ability to identify anomalous data and site errors allowing for highly efficient site monitoring and a significant reduction in costs as well as regulatory submission risk. CluePoints is seeking outstanding candidates with strong project leadership skills and a passion for delivery excellence, to help drive customer success and broad adoption of the CluePoints solution. CluePoints was founded in 2012. We are a young start-up of currently 33 people from 8 nationalities, established in Belgium and USA. And we have fruits, drinks, perks, darts, a kicker and a PlayStation in our relax room…

lire plus


Vous agissez en tant qu’expert scientifique du département production. Dans le cadre de cette nouvelle fonction, vous assurez les missions générales suivantes : - Superviser l’amélioration continue des produits déjà commercialisés ; - Superviser les investigations des problèmes scientifiques et de processus existants dans la production ; - Participer à la validation les nouvelles matières premières ; - Assurer le rôle de backup de responsable de l’équipe Formulation ; - Assurer le rôle de référent scientifique au sein du département production ; - Participer aux scaling up et aux transferts des nouveaux produits.

lire plus


Belrobotics is a Belgian company and is a member of Yamabiko Corporation. It is the world leader in commercial-scale automatic lawn mowers for large areas: Belrobotics designs, manufactures and sells robot mowers for turf areas up to 20,000 m2 and automatic ball pickers that collect golf balls on practices. Belrobotics robots are currently used across Europe to maintain sports facilities (football, rugby, golf courses), private gardens and large open spaces. More information can be found at www.belrobotics.com. Based in Japan, Yamabiko is a global company with major markets in Japan and the Americas and a growing business presence in Europe, Asia, and other countries. More information can be found at www.yamabiko-corp.co.jp/english/

lire plus


e-Xstream engineering (www.e-Xstream.com) is a software & engineer services company 100% focused on the multi-scale modeling of composite materials & Structures. We help our customers, material suppliers and material users across the industries (Auto, Aero,…), to reduce the cost and time needed to develop innovative materials and products using DIGIMAT, the nonlinear material modeling platform. e-Xstream was founded in 2003 in Belgium and Luxembourg. e-Xstream is an MSC Software company (www.mscsoftware.com) since September 2012. Today, e-Xstream core team counts 60 material-dedicated engineers within MSC software, a Hexagon AB Company (hexagon.com), a leading global provider of information technology solutions.

lire plus


Technical Support Engineer

eWON is a company founded in 2001. Over the last 15 years, we (eWON) have become a leading player in the market for intelligent Internet-based Remote Access products, and work with manufacturers of PLCs and automation systems throughout the world. With our cutting-edge technological expertize, combined with excellent knowledge of the Remote Access needs of the industry, we have stood out because of our innovation, passion, integrity, quality and long-term vision. We’re looking for a Technical Support Engineer to consolidate the team.

lire plus






eWON est une société innovante dans le développement de solutions de maintenance à distance. eWON propose aujourd'hui, dans le monde entier, sa gamme de routeurs industriels et des solutions programmables qui fournissent une connectivité sécurisée par Internet. Plus d’infos sur le site internet eWON : https://ewon.biz/fr eWON est à la recherche d’un Ingénieur en électronique avec une expérience minimum de 3 ans en production, R&D ou design. Le/La candidat(e) évoluera vers un rôle d’assurance qualité dans un environnement Manufacturing.

lire plus